FORM 3
        	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
	OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Nielsen Anne	2. Date of Event Requiring Statement (MM/DD/YYYY)
9/1/2013 
	3. Issuer Name and Ticker or Trading Symbol

BRISTOL MYERS SQUIBB CO [BMY]	
(Last)        (First)        (Middle)

BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVENUE	4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Compliance & Ethics Off /	
(Street)

NEW YORK, NY 10154       

(City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)

	6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Beneficially Owned	
1.Title of Security
(Instr. 4)	2. Amount of Securities Beneficially Owned
(Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)	4. Nature of Indirect Beneficial Ownership
(Instr. 5)	
Common Stock, $0.10 par value  	33181.195  	D  	 	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 4)	2. Date Exercisable and Expiration Date
(MM/DD/YYYY)	3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)	6. Nature of Indirect Beneficial Ownership
(Instr. 5)	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				
Market Share Units  	  (1)	3/2/2014  	Common Stock, $0.10 par value  	914.0  	  (2)	D  	 	
Market Share Units  	  (3)	3/1/2015  	Common Stock, $0.10 par value  	2065.0  	  (2)	D  	 	
Market Share Units  	  (4)	3/6/2016  	Common Stock, $0.10 par value  	2172.0  	  (2)	D  	 	
Market Share Units  	  (5)	3/10/2017  	Common Stock, $0.10 par value  	2755.0  	  (2)	D  	 	
Performance Shares  	  (6)	3/31/2014  	Common Stock, $0.10 par value  	5757.6828  	  (7)	D  	 	
Performance Shares  	  (8)	3/31/2015  	Common Stock, $0.10 par value  	1839.9207  	  (9)	D  	 	

Explanation of Responses:	
(  1) 	These market share units will vest on March 2, 2014.	
(  2) 	Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.	
(  3) 	One-half of these market share units will vest on each of March 1, 2014 and March 1, 2015.	
(  4) 	One-third of these market share units will vest on each of March 6, 2014, March 6, 2015, and March 6, 2016.	
(  5) 	Twenty-five percent of the market share unit award will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 10, 2014.	
(  6) 	Consists of 5,317 performance shares and 440.6828 performance shares representing dividend equivalents earned under the 2011-2013 Long-Term Performance Award.	
(  7) 	Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.	
(  8) 	Consists of 1,740 performance shares and 99.9207 performance shares representing dividend equivalents earned under the 2012-2014 Long Term Performance Award.	
(  9) 	Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.	

Remarks:
Exhibit 24 - Power of Attorney	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Nielsen Anne
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK, NY 10154			Chief Compliance & Ethics Off		

Signatures		
/s/ Robert J. Wollin, attorney-in-fact for Anne Nielsen		9/3/2013	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.	

Exhibit 24

                                    POWER OF ATTORNEY
         I, Anne Nielsen, Chief Compliance and Ethics Officer of
Bristol-Myers Squibb Company (the "Company"), a corporation duly
organized and existing under the laws of the State of Delaware, in
the United States of America, and having its principal place of business
at 345 Park Avenue, New York, New York, do hereby constitute and
appoint each of Sandra Leung, Katherine R. Kelly, and Robert J. Wollin,
individually, as my lawful attorney-in-fact and in my name, place and stead
to execute and deliver any and all documents relating to insider reporting
requirements under Section 16 of the Securities Exchange Act of 1934, with
respect to securities issued by the Company, including, without limitation,
the execution and filing of all Forms 3, 4 and 5, and to take such other
action, as such attorney considers necessary or appropriate, to effectuate
such transactions.  This Power of Attorney shall remain in full force and effect
until I am no longer required to file Forms 3, 4, and 5 with respect to securities
issued by the Company, unless earlier revoked.

         IN WITNESS WHEREOF, I have executed this Power of Attorney on this
1st day of September, 2013.

                        /s/ Anne Nielsen
                        Anne Nielsen